Evidence for gamma and beta sensory gating deficits as translational endophenotypes for schizophrenia

Psychiatry Research - Neuroimaging

Volumn 214, Issue 2, 2013, Pages 169-174

  Smucny, Jason ^a,c   Wylie, Korey ^b,c   Rojas, Donald ^a,b,c   Stevens, Karen ^b,c   Olincy, Ann ^b,c   Kronberg, Eugene ^c   Zheng, Lijun ^c   Tregellas, Jason ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Beta; Gamma; Gating; Nicotinic; Schizophrenia

Indexed keywords

BUNGAROTOXIN RECEPTOR; PROTEIN P50;

ADULT; ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; ENDOPHENOTYPE; EVOKED RESPONSE; FEMALE; HETEROZYGOTE; HIGH FREQUENCY OSCILLATION; HIPPOCAMPAL CA3 REGION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING; WILD TYPE;

BETA; GAMMA; GATING; NICOTINIC; SCHIZOPHRENIA;

ADULT; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANALYSIS OF VARIANCE; ANIMALS; BRAIN WAVES; ELECTROENCEPHALOGRAPHY; ENDOPHENOTYPES; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, TRANSGENIC; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SENSORY GATING; TIME FACTORS;

EID: 84884814329     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.07.002     Document Type: Article

References (45)

1. Adams C.E., Stitzel J.A., Collins A.C., Freedman R. Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons. Brain Research 2001, 922:180-190.
2. Adams C.E., Yonchek J.C., Zheng L., Collins A.C., Stevens K.E. Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. Brain Research 2008, 1194:138-145.
3. Adler L., Pachtman E., Franks R., Pecevich M., Waldo M., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry 1982, 17:639-654.
4. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin 1998, 24:189-202.
5. Araud T., Graw S., Berger R., Lee M., Neveu E., Bertrand D., Leonard S. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of alpha7 nAChR function. Biochemical Pharmacology 2011, 82:904-914.
6. Bak N., Glenthoj B.Y., Rostrup E., Larsson H.B., Oranje B. Source localization of sensory gating: a combined EEG and fMRI study in healthy volunteers. Neuroimage 2011, 54:2711-2718.
7. Bibbig A., Faulkner H.J., Whittington M.A., Traub R.D. Self-organized synaptic plasticity contributes to the shaping of gamma and beta oscillations in vitro. The Journal of Neuroscience 2001, 21:9053-9067.
8. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., Freedman R. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biological Psychiatry 1990, 27:183-192.
9. Cao Y.A., Featherstone R.E., Gandal M.J., Liang Y., Jutzeler C., Saunders J., Tatard-Leitman V., Chen J., Weinberger D.R., Lerman C., Siegel S.J. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behavioral Neuroscience 2012, 126:332-343.
10. Clementz B.A., Blumenfeld L.D., Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport 1997, 8:3889-3893.
11. Clementz B.A., Geyer M.A., Braff D.L. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophrenia Research 1998, 30:71-80.
12. Eckhorn R., Bauer R., Jordan W., Brosch M., Kruse W., Munk M., Reitboeck H.J. Coherent oscillations: a mechanism of feature linking in the visual cortex? Multiple electrode and correlation analyses in the cat. Biological Cybernetics 1988, 60:121-130.
13. Freedman R., Adams C.E., Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. Journal of Chemical Neuroanatomy 2000, 20:299-306.
14. French N.R., Steinberg J.C. Factors governing the intelligibility of speech sounds. The Journal of the Acoustical Society of America 1947, 19:90-119.
15. Haenschel C., Baldeweg T., Croft R.J., Whittington M., Gruzelier J. Gamma and beta frequency oscillations in response to novel auditory stimuli: a comparison of human electroencephalogram (EEG) data with in vitro models. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7645-7650.
16. Hall M.H., Taylor G., Salisbury D.F., Levy D.L. Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives. Schizophrenia Bulletin 2011, 37:1187-1199.
17. Hong L.E., Buchanan R.W., Thaker G.K., Shepard P.D., Summerfelt A. Beta (~16Hz) frequency neural oscillations mediate auditory sensory gating in humans. Psychophysiology 2008, 45:197-204.
18. Hong L.E., Summerfelt A., McMahon R.P., Thaker G.K., Buchanan R.W. Gamma/beta oscillation and sensory gating deficit in schizophrenia. Neuroreport 2004, 15:155-159.
19. Hong L.E., Summerfelt A., Mitchell B.D., McMahon R.P., Wonodi I., Buchanan R.W., Thaker G.K. Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate. Archives of General Psychiatry 2008, 65:1008-1016.
20. Kopell N., Ermentrout G.B., Whittington M.A., Traub R.D. Gamma rhythms and beta rhythms have different synchronization properties. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1867-1872.
21. Kucinski A., Syposs C., Wersinger S., Bencherif M., Stachowiak M.K., Stachowiak E.K. alpha7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia. Schizophrenia Research 2012, 136:82-87.
22. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Olincy A., Ross R.G., Adler L.E., Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry 2002, 59:1085-1096.
23. Mathiak K., Ackermann H., Rapp A., Mathiak K.A., Shergill S., Riecker A., Kircher T.T. Neuromagnetic oscillations and hemodynamic correlates of P50 suppression in schizophrenia. Psychiatry Research: Neuroimaging 2011, 194:95-104.
24. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. The British Journal of Medical Psychology 1961, 34:103-116.
25. Miller C.L., Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience 1995, 69:371-381.
26. Miwa J.M., Freedman R., Lester H.A. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 2011, 70:20-33.
27. Olincy A., Braff D.L., Adler L.E., Cadenhead K.S., Calkins M.E., Dobie D.J., Green M.F., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Nuechterlein K.H., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Wagner B.D., Freedman R. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophrenia Research 2010, 119:175-182.
28. Olincy A., Harris J.G., Johnson L.L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G.O., Leonard S., Stevens K.E., Stevens J.O., Martin L., Adler L.E., Soti F., Kem W.R., Freedman R. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Archives of General Psychiatry 2006, 63:630-638.
29. Pena M., Melloni L. Brain oscillations during spoken sentence processing. Journal of Cognitive Neuroscience 2012, 24:1149-1164.
30. Pollack I. Effects of high pass and low pass filtering on the intelligibility of speech in noise. The Journal of the Acoustical Society of America 1948, 20:259-266.
31. Potter D., Summerfelt A., Gold J., Buchanan R.W. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophrenia Bulletin 2006, 32:692-700.
32. Roach B.J., Mathalon D.H. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophrenia Bulletin 2008, 34:907-926.
33. Shahin A.J., Picton T.W., Miller L.M. Brain oscillations during semantic evaluation of speech. Brain and Cognition 2009, 70:259-266.
34. Smucny J., Olincy A., Eichman L.C., Lyons E., Tregellas J.R. Early sensory processing deficits predict sensitivity to distraction in schizophrenia. Schizophrenia Research 2013, 147(1):196-200.
35. Spencer K.M. The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modeling. Frontiers in Human Neuroscience 2009, 3:33.
36. Stephens S.H., Logel J., Barton A., Franks A., Schultz J., Short M., Dickenson J., James B., Fingerlin T.E., Wagner B., Hodgkinson C., Graw S., Ross R.G., Freedman R., Leonard S. Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophrenia Research 2009, 109:102-112.
37. Stevens K.E., Cornejo B., Adams C.E., Zheng L., Yonchek J., Hoffman K.L., Christians U., Kem W.R. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice. Brain Research 2010, 1352:140-146.
38. Stevens K.E., Freedman R., Collins A.C., Hall M., Leonard S., Marks M.J., Rose G.M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 1996, 15:152-162.
39. Tallon-Baudry C., Bertrand O. Oscillatory gamma activity in humans and its role in object representation. Trends in Cognitive Sciences 1999, 3:151-162.
40. Thoma R.J., Hanlon F.M., Moses S.N., Ricker D., Huang M., Edgar C., Irwin J., Torres F., Weisend M.P., Adler L.E., Miller G.A., Canive J.M. M50 sensory gating predicts negative symptoms in schizophrenia. Schizophrenia Research 2005, 73:311-318.
41. Tiitinen H., Sinkkonen J., Reinikainen K., Alho K., Lavikainen J., Naatanen R. Selective attention enhances the auditory 40-Hz transient response in humans. Nature 1993, 364:59-60.
42. Tregellas J.R., Olincy A., Johnson L., Tanabe J., Shatti S., Martin L.F., Singel D., Du Y.P., Soti F., Kem W.R., Freedman R. Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology 2010, 35:938-942.
43. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin 2007, 33:69-94.
44. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I, Finkelstein J., Paz J.T., Stehfest K., Fudim R., Ramakrishnan C., Huguenard J.R., Hegemann P., Deisseroth K. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
45. Zhang Z.J., Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophrenia Research 2002, 55:1-10.